Dendritic cell vaccine for glioblastoma
Treatments studied
Part of Cancer clinical trials.
This trial tests a personalized vaccine made from your own immune cells to see if it can help treat glioblastoma. If you are currently getting standard treatments like surgery, chemo, and radiation, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with glioblastoma and your doctor has confirmed your IDH mutation status.
- You are currently receiving standard treatment, which includes surgery, chemotherapy, and radiation therapy.
- You had an MRI before starting your current treatment.
- You can come to the hospital for checkups every 2 months.
- Your performance status score is greater than 50, meaning you are able to do most daily activities.
- Your tumor cells can be grown in a lab to make the vaccine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized vaccine made from your own immune cells (dendritic cells) to treat glioblastoma that has come back after standard treatment. The vaccine is designed to help your immune system recognize and attack your tumor.
This Phase 2 study tests a personalized glioblastoma vaccine made from your own immune cells (collected by apheresis) and your own tumor material. It’s meant to help your immune system recognize and attack the cancer after standard chemotherapy and radiation.
This trial tests whether adding a personalized vaccine made from your own immune cells and tumor can help standard chemotherapy and radiation work better against glioblastoma. It is for patients who have already had surgery and are starting or have just finished their first round of chemoradiation.
This trial tests a personalized vaccine (made from your own immune cells and tumor 'neoantigens') combined with the chemotherapy drug temozolomide for people with newly diagnosed glioblastoma. The goal is to see if adding the vaccine helps the immune system better fight the tumor.
This trial tests a personalized immune therapy made from your own cells (dendritic cells) that target a protein called survivin in glioblastoma. It's given after standard radiation and chemotherapy, and may help your immune system fight the cancer.
This trial tests whether testing drugs on your tumor cells in a lab can help find the best treatment for you. It is for people with a specific type of glioblastoma that has not been treated yet.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.